返回
China Shineway Pharmaceutical Group Limited（CSWYF）價格
CSWYF 股價走勢圖
CSWYF 財務
China Shineway Pharmaceutical Group Limited
$1
0%
$0
截至今日：Jan 27, 11:58:03 GMT-5
收入
資產負債表
現金流量
年度
每季
CSWYF 收入
財務數據以百萬美元計。會計年度為二月至一月。
Follow-Up Questions
China Shineway Pharmaceutical Group Limited 的關鍵財務報表是什麼？
CSWYF 的關鍵財務比率是什麼？
China Shineway Pharmaceutical Group Limited 的收入按細分市場或地理位置如何劃分？
China Shineway Pharmaceutical Group Limited 是否盈利？
China Shineway Pharmaceutical Group Limited 有負債嗎？
China Shineway Pharmaceutical Group Limited 的流通股有多少？
關鍵數據
前收市價
$1
開盤價
$1
當日範圍
$0.9253 - $1
52週區間
$0.9253 - $1
交易量
100
平均成交量
0
每股盈餘 (TTM)
0.21
股息收益率
--
市值
$758.4M
什麼是 CHINA SHINEWAY PHARMACEUTICAL G？
China Shineway Pharmaceutical Group Ltd. is an investment holding company, which engages in the research and development, manufacturing, and trading of Chinese pharmaceutical products. The company is headquartered in Shijiazhuang, Hebei and currently employs 2,867 full-time employees. The company went IPO on 2004-12-02. The Company’s product dosage forms include injections, soft capsules, granules, traditional Chinese medicine (TCM) granules, oral products and other dosage forms. The Company’s products include Qing Kai Ling Injection, Shen Mai Injection, Wu Fu Xin Nao Qing Soft Capsule, Qing Kai Ling Soft Capsule, Huamoyan Granule, Compound Licorice Tablet and other products, applied to influenza, cardio-cerebrovascular, respiratory system and other disease fields. The firm operates its business in mainland China and Hong Kong markets.